Emergence of serogroup X meningococcal disease in Africa: Need for a vaccine

This publication has 103 references indexed in Scilit:

• Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity
  Clinical Infectious Diseases, 2012
• Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data
  The Lancet Infectious Diseases, 2012
• Analysis of the Bactericidal Response to an Experimental Neisseria meningitidis Vesicle Vaccine
  Clinical and Vaccine Immunology, 2012
• Study of a Localized Meningococcal Meningitis Epidemic in Burkina Faso: Incidence, Carriage, and Immunity
  The Journal of Infectious Diseases, 2011
• Changes in Serogroup and Genotype Prevalence Among Carried Meningococci in the United Kingdom During Vaccine Implementation
  The Journal of Infectious Diseases, 2011
• Neisseria meningitidis is structured in clades associated with restriction modification systems that modulate homologous recombination
  Proceedings of the National Academy of Sciences, 2011
• Meningococcal carriage and disease—Population biology and evolution
  Published by Elsevier ,2009
• Meningococcal Factor H–Binding Protein Variants Expressed by Epidemic Capsular Group A, W‐135, and X Strains from Africa
  The Journal of Infectious Diseases, 2009
• Antibiotic Susceptibility and Characteristics of Neisseria meningitidis Isolates from the African Meningitis Belt, 2000 to 2006: Phenotypic and Genotypic Perspectives
  Antimicrobial Agents and Chemotherapy, 2009
• No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales
  The Lancet Infectious Diseases, 2006